Pfizer Launches Biosimilar Trastuzumab In US

Rival To Herceptin Competes In An Increasingly Crowded Market

 
• By David Wallace
F1
Pfizer has entered an increasingly crowded field with biosimilar trastuzumab • Source: Shutterstock

More from Biosimilars

More from Products